Together we will beat cancer


Lung cancer is the third most common cancer in the UK, with around 48,500 people diagnosed each year. There are two main types of lung cancer – small cell lung cancer and non small cell lung cancer – depending on how the cells look under the microscope.

The main symptoms are a cough, shortness of breath and weight loss.

ASCO 2021 news: follow-up treatments pave the way

One of the biggest meetings of the world’s cancer specialists took place this weekend. Here’s a flavour of the some of the top research presented.

Read More

GPs report ‘perfect storm’ of problems leading to 20,000 drop in urgent referrals for lung cancer

Reluctance to attend hospital tests and come forward about symptoms could be contributing to delays in lung cancer diagnosis.

Read More

‘Thousands’ of lung cancer cases going undiagnosed in England

Health officials are urging people to get symptoms checked, after figures suggest that thousands of people in England could have undiagnosed lung cancer.

Read More

Potentially life-extending treatment for lung cancer available in England

A potentially life-extending treatment for some people with non small cell lung cancer (NSCLC) will now be available on the NHS in England.

Read More

Three new cancer drugs approved for NHS in Scotland

The three latest SMC decisions will provide new treatment options for some adults with non small cell lung cancer, multiple myeloma and a rare type of lymphoma.

Read More

COVID-19 referral drop fears for lung cancer patients in Wales

Confusion over the symptoms of lung cancer and COVID-19 may be responsible for a drop in the number of people being referred for lung cancer tests in Wales.

Read More

Four new cancer drugs approved on NHS in Scotland

The Scottish Medicines Consortium (SMC) has approved 4 new cancer drugs for use on the NHS in Scotland to treat some lung, breast and prostate cancers.

Read More

Lung cancer risks becoming ‘forgotten disease’ of the coronavirus pandemic  

At least 14,000 fewer people have been urgently referred for lung cancer tests since March. 

Read More

Targeted drug for lung cancer approved for NHS use in England

The National Institute for Health and Care Excellence has approved the drug osimertinib to treat some adults in England with untreated, advanced lung cancer.

Read More

US lung cancer data points to the power of cancer research

New data suggest that targeted therapy seems to be having an impact on the treatment of lung cancer.

Read More